Literature DB >> 16882492

Carcinoid tumors.

Rebecca S Sippel1, Herbert Chen.   

Abstract

Carcinoid tumors can present a difficult diagnostic and therapeutic dilemma. Despite their reputation as indolent tumors, they frequently metastasize and can cause significant symptomatology. The only curative therapy remains surgical resection. The prognosis and treatment of carcinoids vary based on location and histology, and therapy must be tailored to each patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882492     DOI: 10.1016/j.soc.2006.05.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  29 in total

1.  Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.

Authors:  Scott N Pinchot; Renata Jaskula-Sztul; Li Ning; Noel R Peters; Mackenzie R Cook; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 2.  Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.

Authors:  Kai Yang; Ying-Sheng Cheng; Ji-Jin Yang; Xu Jiang; Ji-Xiang Guo
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Surveillance of small rectal carcinoid tumors in the absence of metastatic disease.

Authors:  Sara E Murray; Rebecca S Sippel; Ricardo Lloyd; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2012-06-16       Impact factor: 5.344

4.  Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.

Authors:  Yash Somnay; Kevin Simon; April D Harrison; Selvi Kunnimalaiyaan; Herbert Chen; Muthusamy Kunnimalaiyaan
Journal:  Anticancer Drugs       Date:  2013-01       Impact factor: 2.248

5.  Lithium inhibits carcinoid cell growth in vitro.

Authors:  David Yu Greenblatt; Mary Ndiaye; Herbert Chen; Muthusamy Kunnimalaiyaan
Journal:  Am J Transl Res       Date:  2010-05-10       Impact factor: 4.060

6.  A study of pipeline drugs in neuroendocrine tumors.

Authors:  Catherine T Anthony; Juan G Bastidas; Jessica L Thomson; John Lyons; James M Lewis; Joshua E Schwimer; Peter Casey; Jennifer Abadie; Daniel J Frey; Yi-Zarn Wang; J Philip Boudreaux; Eugene A Woltering
Journal:  J Gastrointest Cancer       Date:  2012-06

7.  Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review.

Authors:  William J Salyers; Kenneth J Vega; Juan Carlos Munoz; Bruce W Trotman; Silvio S Tanev
Journal:  World J Gastrointest Oncol       Date:  2014-08-15

8.  Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.

Authors:  David Yu Greenblatt; Max Cayo; Li Ning; Renata Jaskula-Sztul; Megan Haymart; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Gastrointest Surg       Date:  2007-09-15       Impact factor: 3.452

Review 9.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

10.  Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.

Authors:  Muthusamy Kunnimalaiyaan; Mary Ndiaye; Herbert Chen
Journal:  Surgery       Date:  2007-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.